Emerging epidemiological trends of multiple sclerosis among adults aged 20-54 years, 1990-2021, with projections to 2035: a systematic analysis for the global burden of disease study 2021

1990-2021年20-54岁成年人多发性硬化症的新兴流行病学趋势及至2035年的预测:2021年全球疾病负担研究的系统分析

阅读:1

Abstract

BACKGROUND: Over recent decades, clinical, scientific, and public awareness of multiple sclerosis (MS) has increased significantly. This study aims to analyze global trends in the incidence, mortality, and disability-adjusted life years (DALYs) of MS among adults aged 20-54 years from 1990 to 2021. METHODS: Using data from the Global Burden of Disease (GBD) database, this study evaluated MS incidence, mortality, and DALYs in adults aged 20-54 years. Data from 204 countries and territories were stratified by age, sex, and geographical location. Annual percentage changes (APC) were calculated using Joinpoint regression, and estimated annual percentage changes (EAPC) were derived through log-linear regression modeling. Bayesian age-period-cohort (BAPC) modeling was employed to forecast future disease burden. FINDINGS: Globally, in 2021, there were 51,904.12 incident MS cases (95% UI, 44,998.80-59,073.37), 4,738.38 deaths (95% UI, 4,492.03-5,024.11), and 512,985.58 DALYs (95% UI, 428,133.20-610,308.62). Between 1990 and 2021, global incidence increased by 49.48% (95% UI, 44.34-55.15%), mortality rose by 18.21% (95% UI, 11.60-25.45%), and DALYs increased by 43.22% (95% UI, 36.79-48.94%). The High SDI region reported the highest rates of incidence (4.38 per 100,000; 95% UI, 3.93-4.83), mortality (0.41 per 100,000; 95% UI, 0.39-0.42), and DALYs (45.00 per 100,000; 95% UI, 37.22-53.12). Regionally, Western Europe had the highest number of cases (10,964.14; 95% UI, 9,572.30-12,318.88). At the national level, the United States reported the most MS incident cases in 2021 (9,388.21; 95% UI, 8,469.23-10,275.59). Sweden had the highest national incidence rate at 10.12 per 100,000 (95% UI, 8.69-11.66), with an EAPC of 0.24 (95% CI, 0.10-0.38). INTERPRETATION: The global incidence, mortality, and DALYs associated with MS have shown increasing trends, although substantial variations persist across different SDI regions. A comprehensive understanding of MS epidemiology is essential for improving global disease prevention and control efforts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。